Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Study Comparing Megestrol Acetate at 800 mg/Day, and Placebo in AIDS Patients With Anorexia and Cachexia

ClinicalTrials.gov ID: NCT00002067

Public ClinicalTrials.gov record NCT00002067. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 8:52 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase III Randomized Double-Blind Study Comparing Megestrol Acetate at 800 mg/Day, and Placebo in AIDS Patients With Anorexia and Cachexia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To compare the effects of megestrol acetate and placebo on body weight, anorexia, cachexia, calorie intake, and nutritional parameters of patients with a confirmed diagnosis of AIDS. To determine whether megestrol acetate relative to placebo improves the perception of well-being among AIDS patients with cachexia. To evaluate megestrol acetate's effect on immune function via skin test reactivity, T4/T8 ratio, and total lymphocytes.

Study identification

NCT ID
NCT00002067
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bristol-Myers Squibb
Industry
Enrollment
Not listed

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Not listed
Last update posted
Oct 2, 2007

United States locations

U.S. sites
14
U.S. states
6
U.S. cities
13
Facility City State ZIP Site status
Dr Mark Goldstein Los Angeles California 90048 —
Summitt Med Ctr / San Francisco Gen Hosp Oakland California 94609 —
Palo Alto Veterans Adm Med Ctr / Stanford Univ Palo Alto California 94304 —
Eisenhower Med Ctr Rancho Mirage California 92270 —
UCD Med Ctr Sacramento California 95817 —
San Francisco AIDS Clinic / San Francisco Gen Hosp San Francisco California 941102859 —
San Francisco Veterans Administration Med Ctr San Francisco California 94121 —
Denver Public Health Dept Denver Colorado 80204 —
Miami Veterans Administration Med Ctr Miami Florida 33125 —
Univ of South Florida Tampa Florida 33612 —
Northwestern Univ Med School Chicago Illinois 60611 —
Mem Sloan - Kettering Cancer Ctr New York New York 10021 —
SUNY / Health Sciences Ctr at Syracuse Syracuse New York 13210 —
Northwest Family Ctr at the Harbor View Med Ctr Seattle Washington 98104 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00002067, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 2, 2007 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00002067 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →